| 121/356 | US=96 / Biol/Mol Márquez-Garbán DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ. Targeting aromatase and estrogen signaling in human non-small cell lung cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 194-205. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. NSCLC; CYP19; EGFR; NAO-PEQUENAS CELULAS DE PULMAO; AROMATASE; RECEPTOR DE ESTROGENO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; ANASTRAZOLE; EXEMESTANO; FULVESTRANT; VANDETANIB |
| 122/356 | US=96 / Biol/Mol Campisi I, Granata OM, Cocciadiferro L, Calabrò M, Polito LM, Carruba G. 16¦Á-hydroxyestrone inhibits estrogen sulfotransferase activity in human liver cancer cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 237-42. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. ESTROG¨ºNIO SULFOTRANSFERASE; MODULADORES SELETIVOS DE RECEPTOR DE ESTROG¨ºNIO; SERMS; 16¦A-OHE1; C¨¦LULAS HEPG2 |
| 123/356 | US=96 / Biol/Mol Miceli V, Cervello M, Azzolina A, Montalto G, Calabrò M, Carruba G. Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 252-6. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. ARO; AREG; HCC; ER; AROMATASE; AMPHIREGULIN; CARCINOMA HEPATOCELULAR HUMANO; RECEPTOR DE ESTROGENO |
| 124/356 | US=96 / Biol/Mol Cocciadiferro L, Miceli V, Kang KS, Polito LM, Trosko JE, Carruba G. Profiling cancer stem cells in androgen-responsive and refractory human prostate tumor cell lines. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 257-62. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. CELULAS-TRONCO DO CANCER; CANCER DE PROSTATA; MARCADORES DE CELULAS-TRONCO; DIFERENCIACAO MARCADORES DE CELULAS; METABOLISMO ANDROGENICO |
| 125/356 | US=96 / Biol/Mol Giuseppe GT, Carruba G, Cocciadiferro L, Granata OM, Nicotra CMA. Low levels of both xanthine dehydrogenase and cellular retinol binding protein are responsible for retinoic acid degiciency in malignant human mannary epithelial cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 268-72. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. ALL-TRANS-RETINOICO; TUMORAIS CELULAS EPITELIAIS MAMARIAS; XANTINA-DESIDROGENASE; CELULAR PROTEINA RETINOL; PROTEINA ACIDO RETINOICO CELULAR VINCULATIVO; BIOSSINTESE DE ACIDO RETINOICO |
| 126/356 | US=96 / Biol/Mol Marotta F, Yadav H, Pathak S, Minelli E, Signorelli P, Lorenzetti A, Marandola P. Inhibition of human breast cancer cell growth and enzymatic activity by a fermented nutraceutical. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 273-7. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. LINHAS CELULARES DE CANCRO DA MAMA; IN VIVO MODELO DE CANCER DE MAMA; MANDA-KOSO |
| 127/356 | US=96 / Biol/Mol Cusimano A, Foderà D, Lampiasi N, Azzolina A, Notarbartolo M, Giannitrapani L, D'Alessandro N, Montalto G, Cervello M. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 300-8. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. HCC; EP RECEPTORES; COX-1; COX-2; NSAIDS; HEPATOCELLULAR CARCINOMA |
| 128/356 | US=101 / Câncer Goh KG, Banks H, Udalova IA. Detecting and modulation the NF-&*1179;B activity in human immune cells: generation of human cell lines with altered levels of NF-Detecting and modulation the NF-&*1179;B. In: Kozlov SV, editor. Inflammation and cancer: methods and protocols. volume 2, molecular analysis and pathways. New York: Humana Press, 2009. p. 39-54. (Methods in Molecular Biology, 512) ISBN 978-1-60327-529-3. MODULACAO DO NF-&*1179;B; NF-&*1179;B; RNA DE INTERFERENCIA; LENTIVIRUS; LINHAS DE CELULAS CLONAIS |
| 129/356 | US=101 / Câncer Ritzenthaler JD, Roman J, ShouWei H. PPARß/&*948; agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells. In: Kozlov SV, editor. Inflammation and cancer: methods and protocols. volume 2, molecular analysis and pathways. New York: Humana Press, 2009. p. 309-23. (Methods in Molecular Biology, 512) ISBN 978-1-60327-529-3. |
| 130/356 | US=23-D / Câncer Kuramitsu Y, Nakamura K,. Hepatitis C virus-related human hepatocellular carcinoma: predictive markers using proteomic analysis (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 343-50. ISBN 978-1-4020-9803-1. VIRUS DA HEPATITE C X CARCINOMA HEPATOCELULAR HUMANO; PROTEOMICA; PROTEOMICA PARA TECIDOS DE CARCINOMA HEPATOCELULAR; PROTEOMICA PARA SOROS FROW PACIENTES COM CARCINOMA HEPATOCELULAR; PROTEOMICA PARA VIRUS DA HEPATITE C TECIDOS RELACIONADOS HEPATOCELULARES |
| 131/356 | US=45-B / Cab/Pesc Gillison ML. Human papillomavirus and prevention and therapy of head and neck cancer. In: Harrison LB, Sessions RB, Hong WK. Head and neck cancer: a multidisciplinary approach. 3rd ed. Philadelphia: J B Lippincott, 2009. p. 905-17. ISBN 978-0-7817-7136-8. |
| 132/356 | US=106 / Câncer Gillison ML. Molecular epidemiology of human papillomavirus infection. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 1-19. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. INFECCAO PELO PAPILOMAVIRUS HUMANO; PAPILOMAVIRUS HUMANO; INFECCAO PELO PAPILOMAVIRUS HUMANO CERVICAL. FATORES DE RISCO; PAPILOMAVIRUS HUMANO. INFECCAO EM HOMENS; INFECCAO POR PAPILOMAVIRUS HUMANO. ANAIS; INFECCAO PELO PAPILOMAVIRUS HUMANO. VIA ORAL EM HOMENS; INFECCAO PELO PAPILOMAVIRUS HUMANO. VIA ORAL EM MULHERES |
| 133/356 | US=106 / Câncer Mao CP. Molecular pathogenesis of the human papillomavirus: cervical cancer as a model. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 20-36. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. PATOGENESE MOLECULAR; PAPILOMAVIRUS HUMANO; CANCER CERVICAL; LESAO INTRAEPITELIAL ESCAMOSA; MODELO EMERGENTE DE PROGRESSAO DO CANCER CERVICAL |
| 134/356 | US=106 / Câncer Roden R, Hung CF, Monie A, Wu TC. Human papillomavirus vaccines. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 37-62. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. HUMANOS VACINAS PAPILOMAVIRUS; HUMANOS VACINAS PAPILOMAVIRUS. PREVENCAO; HUMANOS VACINAS PAPILOMAVIRUS. TRATAMENTO; PEPTIDO / PROTEINA BASEADA EM VACINAS; BASEADOS EM CELULAS VACINAS; TUMOR DE CELULAS VACINAS BASEADAS; NUCLEICOS VACINAS A BASE DE ACIDO; COMBINACAO DE VACINAS PREVENTIVAS E TERAPEUTICAS; MODALIDADE VACINAS DE COMBINACAO |
| 135/356 | US=106 / Câncer LaFemina RL. Hepatitis C virus genetics and the discovery of mechanism-based inhibitors of the NS3/4A protease and NS5B polymerase. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 62-93. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. VIRUS DA HEPATITE C; MECANISMO; INIBIDORES DA PROTEASE; HEPATITE REPLICACAO DO VIRUS C; TERAPIA ANTIVIRAL ATUAL; VIRUS DA HEPATITE C NS3/4A PROTEASE |
| 136/356 | US=106 / Câncer Toh ST, Lee CG. Role of the hepatitis B virus in hepatocellular carcinoma. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 94-107. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. PAPEL DO VIRUS DA HEPATITE B. CARCINOMA HEPATOCELULAR; CARCINOMA HEPATOCELULAR; HEPATITE B VIRAL; HEPATOCARCINOGENESE |
| 137/356 | US=106 / Câncer Cougot D, Buendia MA, Neuveut C. Carcinogenesis induced by hepatitis B virus. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 108-36. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. VIRUS DA HEPATITE B, ARCINOGENESE; HEPATITE B. GENOMA DO VIRUS; PROTEINAS VIRAIS. ROPRIEDADES ONCOGENICAS; CARCINOMA HEPATOCELULAR |
| 138/356 | US=106 / Câncer Ambinder RF. Disease and pathogenesis associated with Epstein-Barr virus. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 137-49. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. VIRUS EPSTEIN-BARR; EBV; TUMORES; TUMORES ESPECIFICOS; DOENCA E PATOGENESE |
| 139/356 | US=106 / Câncer Martin HJ, Hayward SD. The biology and molecular biology underlying Epstein-Barr virus oncogenesis. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 150-69. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. VIRUS EPSTEIN-BAR. ONCOGENESE; EPSTEIN-BARR. BIOLOGIA; EPSTEIN-BARR. EXPRESSAO DE GENES PROGRAMAS; VIRUS EPSTEIN-BARR PERSISTENCIA |
| 140/356 | US=106 / Câncer Damania B, Dittmer DP. Kaposi-sarcoma-associated herpesvirus. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 170-85. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. SARCOMA DE KAPOSI ASSOCIADO HERPESVIRUS; SARCOMA DE KAPOSI; SARCOMA DE KAPOSI LINFOMA |